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ABSTRACT  
Objective 
Clinicians may record patients presenting with osteoarthritis (OA) symptoms with joint pain 
rather than an OA diagnosis. This may have implications for OA research studies and patient 
care. The objective was to assess whether older adults recorded with joint pain are similar to 
those with a recorded OA diagnosis. 
Method 
A study of adults aged ≥50 years in eight United Kingdom general practices, with electronic 
health records linked to survey data. Patients with a recorded regional OA diagnosis were 
compared to those with a recorded joint pain symptom on socio-demographics, risk factors, 
body region, pain severity, prescribed analgesia, and potential differential diagnoses. A sub-
group were compared on radiographic knee OA. 
Results 
13,831 survey responders consented to record review. 1427 (10%) received an OA (n=616) 
or joint pain (n=811) code with wide practice variation. Receiving an OA diagnosis was 
associated with age (75+ compared to 50-64 OR 3.25; 95%CrI 2.36, 4.53), obesity (1.72; 
1.22, 2.33), and pain interference (1.45; 1.09, 1.92). Analgesia management was similar. 
Radiographic OA was common in both groups. A quarter of those with a joint pain record 
received an OA diagnosis in the following six years.  
Conclusion 
Recording OA diagnoses is less common than recording a joint pain symptom and associated 
with risk factors and severity. OA studies in primary care need to consider joint pain 
symptoms to understand the burden and quality of care across the spectrum of OA. Patients 
recorded with joint pain may represent early cases of OA with need for early intervention. 
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Osteoarthritis, Computerized Patient Medical Records, Primary Health Care  
Running title 
Osteoarthritis diagnosis in primary care   
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
 
INTRODUCTION 
In the UK, the initial presentation and management of osteoarthritis (OA) most commonly 
occurs within primary care. The UK National Institute for Health and Care Excellence 
(NICE) guidance recommends application of a working diagnosis of OA in adults 45 years 
and older presenting with persistent joint pain, not associated with lasting morning stiffness, 
but excluding those with atypical features of OA1. EULAR guidelines recommend making a 
diagnosis of knee OA based on knowledge of the underlying population prevalence and the 
presence of patient risk factors for OA, their symptoms, and physical examination2.Whilst 
both guidelines infer that an OA diagnosis can normally be made without recourse to further 
investigation, there are likely to be instances of diagnostic uncertainty.  
 
In primary care, health-related information including diagnosis is typically electronically 
recorded and coded. In the UK the most common system used is the Read code classification3 
which allows health care professionals to label a presenting complaint with a symptom or 
disease-based Read code. Thus, OA-related symptoms may be categorised as joint pain codes 
rather than as an OA diagnosis. A study assessing the completeness of recorded diagnoses in 
primary care found a low sensitivity of 63% for OA, with a major reason being use of 
alternative codes, such as knee pain, by clinicians4. Even accounting for patients not seeking 
health care, there appears to be a wide discrepancy between the estimates of self-reported 
symptomatic OA and the prevalence of primary care recorded OA diagnosis. In the UK, it 
has been estimated that 53% of older adults report chronic joint pain, and 22% severe 
disabling pain5, but only 13% of older adults in the same geographical region received an OA 
diagnosis over a seven year period6. A study in Sweden found only 63% of those with 
symptomatic knee OA had a recorded knee OA diagnosis within an 8 year period7. A prior 
study of ours showed there may be 10 years between recording of initial symptoms of knee 
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pain and a recorded OA diagnosis in primary care8. The threshold for diagnosing and 
subsequently coding OA is likely to be variable, dependent on, for example, the individual 
practitioner’s personal preference in coding, perceived reaction of the patient to receiving an 
OA diagnosis, or extent of uncertainty in diagnosis and wish for further confirmation such as 
radiographic evidence.  
 
Understanding the spectrum of OA that is captured by a diagnosis code is important for 
several reasons. Primary care records are increasingly being used as a sampling frame for 
recruitment to trials and cohort studies, and to estimate morbidity prevalence and incidence in 
order to direct future health service planning9. Excluding older patients with joint pain 
symptom codes may result in selective populations in studies of OA, and under-estimated 
consultation prevalence and incidence of OA that has been shown in both the UK and 
Sweden6,10. There is also some evidence that those recorded with a joint pain symptom rather 
than an OA diagnosis have different patterns and quality of care11. 
 
The objective of this study was first to assess, within a cohort with linked self-report and 
medical record information, whether older adults with a recorded joint pain symptom in 
primary care have similar risk factors and pain characteristics, management, and existence of 
potential alternative diagnoses as those with a recorded OA diagnosis. The hypotheses tested 
are described in box 1, with the underlying null hypothesis that only the recording practices 
of clinicians differentiates those with an OA diagnosis and those with a joint pain symptom 
record. The second objective was to determine the percentage of older adults recorded with a 
joint pain symptom who had a recorded OA diagnosis within the next 6-7 years. 
 
METHODS 
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The North Staffordshire Osteoarthritis Project (NorStOP) was a longitudinal survey of all 
those aged 50 plus registered at 8 general practices. In the UK, most  people are registered 
with a general practice and therefore the registers provide a convenient sampling frame for 
the local population. At baseline the GPs at the practices excluded those with severe illness 
(for example, severe psychiatric or terminal illness) and questionnaires were then mailed to 
the remaining registered population aged 50 and over with reminders sent after two and four 
weeks. Further questionnaires were mailed at 3 years and 6-7 years12,13. Self-reported survey 
data was linked to primary care records (with consent) with records collated from 24 months 
prior to the baseline survey to either the date of the 6-7 year survey or the date the participant 
dropped out of the study (for example, if the participant did not respond to the 3 year survey, 
collation of the records ended then). The primary care record follow up lasted a median of 6.4 
years from the baseline survey (IQR 3.7, 6.9).  
 
We previously identified through consensus of general practitioners (GPs) a set of Read 
codes relating to non-specific joint pain (hand, hip, knee, foot) which could be used by GPs 
as an alternative to an OA diagnosis code for older patients presenting with likely OA6,11 and 
are available from the authors. Two groups were identified for this analysis from all NorStOP 
baseline respondents who consented to medical record review, based on their primary care 
consultation records for the 12 months before the baseline survey. Group 1 received an OA 
diagnostic code during the 12 months (OA group); group 2 received a joint pain symptom 
code but not an OA diagnostic code during those 12 months (joint pain group). Respondents 
who received both an OA diagnostic code and a joint pain code were included in the OA 
group. Both groups included patients with ongoing problems and those consulting with new 
problems. The index date was the date of the recorded OA / joint pain code nearest to the 
baseline survey within this twelve month time period. Respondents for whom a body region 
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(knee, hip, hand/wrist, foot/ankle) at the index date consultation could not be allocated, either 
through the code given or recorded in the free text of the consultation, were excluded in order 
to allow comparison by individual site.  
 
In order to address the hypotheses stated in box 1, information on pain medication 
prescribing and differential diagnoses were extracted from the medical records, information 
on socio-demographic risk factors, extent of pain, pain interference, BMI, and anxiety and 
depression were identified from the baseline survey, and radiographic information from a 
subset of respondents undergoing radiographs.  
 
The OA and joint pain groups were first compared on socio-demographic risk factors (age, 
gender, socioeconomic status) and other known or proposed risk factors (body mass index 
(BMI), depression or anxiety) measured in the baseline survey2,14,15. They were also 
compared on body region consulted for at index consultation, extent of and interference from 
pain at time of baseline survey, and analgesia management (at time of index consultation). 
 
Socio-economic status was based on reported current or last job16, and categorised into low 
social class (lower supervisory, lower technical, semi-routine or routine occupations), high 
social class (managerial/professional, intermediate occupations/self-employed) and unknown 
based on the highest social class of the individual or their spouse. 
 
Extent of pain was measured by self-reported number of sites of pain over the past 12 months 
(count of knee, hip, hand and foot) in the baseline survey. This was based on four questions, 
one for each site, with answer options of yes or no. For example, the question relating to foot 
pain was “Have you had pain in the last year in and around the foot?”. Pain interference was 
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defined using the Short Form-12 item “During the past 4 weeks, how much did pain interfere 
with your normal work (including both work outside the home and housework)”. 
Respondents who responded “moderately”, “quite a bit” or “extremely” were rated as having 
pain interference, whilst those who responded “not at all” or “a little bit” were regarded as 
not having pain interference13,17-19. 
 
BMI was determined using self-reported height and weight and categorised as normal / 
underweight (BMI ≤ 25 kg/m2), overweight (>25-30), and obese (>30). Anxiety and 
depression in the baseline survey were classified using the Hospital Anxiety and Depression 
Scale (HADS)20. The HADS contains 14 items from which a score (range 0-21) for each of 
anxiety and depression  can be determined. Scores of 8 or more on either domain indicate 
possible or probable anxiety or depression. 
 
Analgesia prescribed at time of the index consultation were identified through the primary 
care records using a hierarchical categorisation derived by Bedson and colleagues21. This 
splits analgesics into basic analgesics (for example, paracetamol), weak or moderate opioids 
(for example, codeine 8mg-15mg), strong opioids (for example, codeine 30mg, morphine and 
oxycodone) and non-steroidal anti-inflammatory drugs (NSAIDs).  Pain medication was 
deemed as being related to an OA or joint pain consultation if it was prescribed on the same 
day as the index consultation, or within 14 days of that consultation. This was to allow for 
patients to take up a ‘delayed’ prescription for analgesics that the GP offered should the 
condition not improve.     
 
Recording of a potential differential diagnosis in the primary care records was also assessed. 
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Differential diagnoses were determined by consensus of 3 GPs and identified in the primary 
care records for the 12 months preceding and 12 months following the date of the index 
consultation. These included inflammatory musculoskeletal diagnoses such as rheumatoid 
arthritis, joint specific diagnoses such as bursitis and enthesopathy, and generalised 
conditions such as fibromyalgia (supplementary table). 
 
A subgroup of the NorStOP respondents who reported knee pain also had plain radiographs 
taken of their knee with three views to capture both tibiofemoral and patellofemoral OA22-25.  
Mild knee OA was defined as a Kellgren and Lawrence (K&L) score of 2 in the 
posteroanterior or skyline view, or a score of 1 or 2 on posterior or lateral osteophytes. 
Moderate/severe knee OA was defined as a K&L score  of ≥3 in the posteroanterior or 
skyline view, or a score of 3 on posterior or lateral osteophytes26. A single reader scored all 
films and was blinded to all questionnaire data. Intraobserver and interobserver  (with a 
second reader) agreement  of posteroanterior K&L score, skyline K&L score and lateral 
osteophytes were assessed on 100 knees. Unweighted kappas for intraobserver reliability 
were between 0.81 and 0.98; interobserver kappas were between 0.49 and 0.7627. The 
proportion of these respondents classified as having no, mild or moderate/severe radiographic 
knee OA their most problematic knee was compared between the knee OA and joint pain 
groups.  
 
Statistical analysis 
Multilevel logistic regression models (patients clustered within practices) were used for the 
analysis. First the variance components model (i.e. with no explanatory variables included) 
was derived to assess the amount of variation in use of an OA diagnosis code that was at the 
practice level compared to that between respondents28. Then associations with a recorded OA 
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diagnosis were determined first unadjusted, and then fully adjusted with all the socio-
demographic and other risk factors, pain extent and interference, and analgesic prescription 
included in the model. Results are reported as odds ratios (OR) with 95% credible intervals 
(95% CrI) obtained through Markov Chain Monte Carlo (MCMC) methods. The analysis was 
repeated in three subgroups: i) those with no recorded OA or joint pain consultation in the 12 
months prior to their index consultation (new episode consulters) to assess whether the 
associations with an OA diagnosis persisted or altered in new consulters, ii) those consulting 
for a problem related to the knee, and iii) those consulting for a problem related to the hip. 
There were too few patients consulting for hand/wrist or foot/ankle to allow further 
exploration of these sites. In the subgroup with radiographs we compared patients receiving a 
knee OA diagnosis to those with a knee joint pain record on presence and severity of knee 
radiographic evidence of OA, unadjusted and adjusting for age and gender.  
 
We also determined the percentage of those in the joint pain group who had a pre-existing 
OA diagnosis in their primary care records in the period 12-24 months before the baseline 
survey, and the percentage recorded with an OA diagnosis, inflammatory musculoskeletal  
condition, joint specific soft tissue diagnosis, or fibromyalgia after the survey during the 
follow up period.  
 
Analyses were performed using runmlwin29, MLwiN 2.2930,31,  and Stata 13.1. 
 
RESULTS 
26,625 people were mailed a baseline questionnaire. Of these, 186 were excluded due to 
death or departure from their practice, 240 had an incorrect address, 22 were subsequently 
found to be ineligible, and 48 were excluded due to severe ill-health. Of the remainder,18,497 
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(71%) responded. 13,831 (75%) of these consented to medical record review. 1741 (13%) 
had received an OA diagnosis or joint pain code in the 12 months prior to the baseline survey, 
of which 1427 were able to be allocated to a body region. Of these 1427, 616 (43%) had a 
recorded OA diagnosis and 811 had a joint pain symptom recorded. However there was 
variation by practice. One practice recorded only 19% with an OA diagnosis, whilst another 
practice recorded 70% with an OA diagnosis. (table 1) Prior to inclusion of explanatory 
variables in the multilevel model, 16% of the variation in coding was at the practice rather 
than respondent level. 
 
Increasing age was strongly associated with receiving an OA diagnosis with those aged 75 
and over having more than 3 times the odds of a recorded OA diagnosis than those aged 50-
64 (adjusted OR 3.25; 95% CrI 2.36, 4.53). Obesity (OR 1.72; 95% CrI 1.22, 2.33) was also 
associated with a recorded OA diagnosis. There were no statistically significant associations 
with gender, social class, or anxiety / depression. (table 2)  
 
Reporting interfering pain was associated with a recorded OA diagnosis (adjusted OR 1.45; 
95% CrI 1.09, 1.92), however 62% of those with a joint pain record reported pain 
interference and the number of self-reported pain sites was statistically significantly 
associated with a recorded OA diagnosis in the unadjusted analysis only. Those consulting 
with a hip problem (OR 0.50; 95% CrI 0.36, 0.67) or foot/ankle problem (OR 0.26; 95% CrI 
0.17, 0.38) were less likely to have a recorded OA diagnosis than someone presenting with a 
knee problem. The prescription of analgesia and strength of analgesia prescribed were similar 
between groups. 
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The associations generally persisted in the subgroups consulting with a new episode and in 
the subgroups with a knee and hip problem (tables 3 and 4) although the associations with 
obesity (OR 1.67; 95% CrI 0.97, 2.64) and pain interference (OR 1.35; 95% CrI 0.82, 1.99) in 
those with a new episode were weaker and became statistically non-significant.  The 
relationship of recorded OA diagnosis with older age was stronger in those with a knee 
problem (age 75+: OR 8.97; 95% CrI 5.32, 14.78). 
 
32% of all those with recorded joint pain and 26% of all those with an OA diagnosis record 
had a possible differential diagnosis in their records (chi-squared test, p=0.014, 
supplementary table). The main difference between the groups was in the presence of another 
or unspecified arthropathy code (11% of the joint pain group compared to 5% of the OA 
group). Those with a hand/wrist problem were most likely to have a differential diagnosis 
(42% of joint pain group and 27% of OA group) and those with a hip problem were least 
likely (25% of joint pain group and 21% of OA group). 
 
In the 124 patients with a knee problem for whom plain knee radiographs were available 
from the nested sub-study, the presence of radiographic features of OA was associated, albeit 
not statistically-significantly, with an OA diagnosis. (table 5) Those with moderate or severe 
radiographic OA had nearly 3 times the odds of an OA diagnosis compared to those without 
radiographic OA (unadjusted OR 2.82; 95% CrI 0.93, 6.78). However, 52% of the joint pain 
group had radiographic evidence of moderate or severe OA. 
 
Of the 811 patients in the joint pain group, 53 (7%) had a prior recorded OA diagnosis (any 
body region) in the period 12-24 months prior to the baseline survey. In the median 6 years 
after the baseline survey, 203 (25%) of the 811 patients in the joint pain group received an 
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OA diagnosis. 25 (3%) of the joint pain patients had a recorded long term inflammatory 
musculoskeletal condition such as rheumatoid arthritis during this same follow-up period, 21 
(3%) had a recorded specific soft tissue diagnosis such as bursitis, and 3 had fibromyalgia 
recorded. In the 447 joint pain patients with a new consulting episode (no joint pain or OA 
record in 12 months prior to index date), 111 (25%) had a recorded OA diagnosis after the 
baseline survey.  
 
DISCUSSION 
Variation exists in the relative recording of joint pain symptoms and OA diagnosis in older 
adults presenting to primary care. Older age, obesity and interference of pain increased the 
likelihood of being recorded with an OA diagnosis although these risk factors were also 
common in those with a joint pain record. However, those with foot and ankle problems were 
less likely to have a recorded OA diagnosis than those with knee problems. Prescription 
management was not associated with an OA diagnosis. 
 
Our a priori hypotheses to test whether older patients with an OA diagnosis record and those 
with a joint pain record are a similar group generally did not hold, except for pain medication 
management, which suggests that there are some distinct differences between those who are 
recorded with an OA diagnosis and those recorded as having a joint pain symptom. It appears 
that GPs may often reserve the diagnosis for those who reach a threshold in severity of 
symptoms, fit the risk factor profile (older age, obese) typically associated with OA, and thus 
in whom they feel more confident in making a positive diagnosis of OA. However, whilst 
there was an elevated likelihood of an OA diagnosis in those with moderate or severe 
radiographic OA, half of those in the joint pain group also had moderate or severe 
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radiographic OA, and over half reported interfering pain, suggesting many of those recorded 
with a joint pain symptom do have severe problems.  
 
Those presenting with a hip or foot/ankle problem were less likely to receive an OA code 
than those presenting with a knee problem. Pain in the foot and ankle in particular may be 
attributed to many conditions other than OA so this may reflect an appropriate level of 
caution by GPs. Those with a hand/wrist joint pain record were more likely to have a 
potential differential diagnosis. Joint pain codes for hand/wrist generally do not relate to 
individual joints in the hand/wrist but to the whole hand or wrist, for example, “hand pain”, 
therefore it was not possible to determine likelihood of OA based on the individual joints 
affected within the hand. A similar limitation occurred for foot/ankle pain. Further research 
needs to assess whether a foot or hand pain code given to older adults is likely to reflect OA. 
 
A quarter of those recorded as a joint pain symptom did receive an OA diagnosis over the 
following 6-7 years, and only 6% received an inflammatory musculoskeletal or specific soft 
tissue diagnosis. This suggests that although GPs may be disinclined to offer a definitive OA 
diagnosis early on, they may be happy to do so after a ‘watch and wait’ policy which may 
allow assessment of therapeutic efficacy, other investigations to be undertaken, or symptoms 
to worsen to aid or help justify diagnosis. Some clinicians may be reluctant to label younger 
patients with a diagnosis of chronic disease. Whilst it is recognised that applying a label to a 
chronic condition such as OA may help to ease the anxiety that compelled the patient to seek 
medical intervention in the first instance, it may also alter the patient’s perception of the 
problem from one of ongoing pain, to a label of a chronic, degenerative, incurable 
condition32,33. Moreover, it has been argued that patients seek treatment for pain and not OA, 
with effective management reliant on presenting symptoms rather than diagnostic label. As 
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such, it has been proposed that joint pain in adults be viewed as a regional pain syndrome 
much like ‘low-back pain’ rather than considered according to its disease-specific cause33, 
allowing treatment to be tailored to meet the patient’s needs rather than diagnosis. The 
similarity in pain medication management between the two groups shown in this study 
suggests that recording a symptom rather than an OA diagnosis does not influence the choice 
of analgesia. However, given there is evidence that the quality of care may differ between 
those with an OA or joint pain label11, further research is needed to assess whether the choice 
of label affects recommended non-pharmacological management such as exercise, weight 
loss advice and referral to physiotherapy. If so, there may be missed opportunities in the 
management of OA, particularly early intervention at the start of health care use for joint pain 
in older adults, in those with initially less severe symptoms.  
 
The choice of recorded label also has public health implications. The electronic patient record 
and consequent collation of primary care consultation data has created opportunities for 
epidemiological studies to inform health care need and service provision. Studies focussing 
only on those with a recorded OA diagnosis will be identifying the older, more severe 
patients, and may underestimate the scale of the burden of OA in primary care, and ignore the 
group who may have fewer of the recognised risk factors but who may progress to a later OA 
diagnosis. Approaches to measure and improve quality of care could also be misguided if 
based only on those with a recorded diagnosis of OA.  
 
The study was limited to one area of the UK, albeit with similar musculoskeletal prevalence 
figures to those shown nationally, including for OA and arthralgia34.  Whilst Read codes are 
the most common method of classification in general practice in the UK, they are not used 
elsewhere. However, we have previously matched Read codes for OA and joint pain to the 
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International Classification of Diseases (ICD-10) and obtained very similar consultation 
prevalence figures for OA and for joint pain in patients aged 45 and over between the UK and 
Sweden6. This suggests that the issues highlighted here may also be of relevance outside of 
the UK. One practice which showed high recording of OA had been trained to preferentially 
record diagnoses due to their inclusion in another research database. Excluding this practice 
did not change the associations shown. The potential differential diagnoses identified may 
relate to a different problem than the OA or joint pain record and so it is not known how 
many of these represent true differential diagnoses. Subsequent diagnoses were also not 
matched to the same body region as the index joint pain consultation. It is possible that the 
recording of an OA diagnosis may also be associated with referral to secondary care but we 
were unable to explore that in this study. Whilst the GP may have recorded the consultation 
with a joint pain symptom, it is possible they informed the patient it was OA. We only 
considered a period of 12 months prior to the survey so that self-reported information was not 
too long after the consultation. There will be other respondents to the survey who had 
consulted and been recorded with an OA diagnosis or joint pain symptom more than 12 
months before the survey but not in the 12 month period considered here.  
 
Recording an OA diagnosis in elderly patients in primary care is less common than recording 
a non-specific joint pain symptom, and is associated with known risk factors and severity of 
the problem. However, those not given an OA diagnosis had high levels of interfering pain 
and radiographic OA. A quarter later received an OA diagnosis. This suggests that 
epidemiological studies of OA in primary care may need to consider joint pain symptoms as 
well as diagnosed OA to understand the true burden and quality of care across the full 
spectrum of OA. There is a need to reduce GP variation in diagnosing OA, and to understand 
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whether there are consequences for the patient with OA symptoms of not being diagnosed 
with OA in terms of missed early opportunities in management of OA.  
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Box 1 – Hypotheses tested to assess the assumption that older patients with a recorded OA 
diagnosis and those with a joint pain symptom record are a homogenous group 
 
People aged 50 and over with a non-specific joint pain symptom record differ from those 
with a recorded OA diagnosis only by recording practice by clinicians and not by: 
i) distribution of perceived risk factors (age, gender, socio-economic status, obesity, 
anxiety/depression)  
• The alternative hypothesis is that an OA diagnosis is more likely to be given to 
patients who have recognised risk factors for OA. 
ii) reporting of more severe symptoms and radiographic evidence  
• The alternative hypothesis is that an OA diagnosis is given to patients with more 
severe symptoms and radiographic features. 
iii) recorded body region (knee, hip, hand/wrist, foot/ankle) 
• The alternative hypothesis is that an OA diagnosis is less likely for those 
presenting with foot/ankle symptoms where other diagnoses (for example, 
tendinitis, plantar fasciitis, gout) may be as likely to be the cause of the problem 
iv) prescription management 
• The alternative hypothesis is that an OA diagnosis is more likely to be given if a 
patient receives stronger analgesia 
v) levels of recording of differential diagnoses 
• The alternative hypothesis is that a joint pain diagnosis relates to an underlying 
non-OA condition 
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Table 1 – Number of patients with a recorded OA diagnosis or joint pain symptom by 
practice 
Practice OA 
  n (%) 
Joint pain 
  n 
Total 
1 176 (70)   77   253 
2   95 (54)   81   176 
3   86 (44) 110   196 
4   50 (37)   84   134 
5   91 (37) 156   247 
6   44 (34)   85   129 
7   50 (31) 113   163 
8   24 (19) 105   129 
Total  616 (43) 811 1427 
   
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
25 
 
Table 2 - Comparison between those with a recorded OA diagnosis and those with a recorded 
non-specific joint pain symptom   
 
 OA  
n (%) 
Joint Pain 
n  
OR (95% CrI)a OR (95% CrI)b 
Total 616 (43) 811   
Male 229 (37) 387 1 1.00 
Female 387 (48) 424 1.21 (0.96, 1.50) 1.14 (0.87, 1.45) 
Age  50-64 201 (34) 389 1.00 1.00 
 65-74 216 (45) 262 1.75 (1.32, 2.24) 1.78 (1.34, 2.34) 
 75+ 199 (55) 160 2.63 (1.98, 3.49) 3.25 (2.36, 4.53) 
Social class            Low 290 (43) 390 1.00 1.00 
High 300 (44) 379 1.04 (0.81, 1.31) 1.02 (0.79, 1.27) 
Unknown 26 (38) 42 0.71 (0.39, 1.16) 0.57 (0.29, 1.02) 
BMI group       Normal 173 (39) 270 1.00 1.00 
Overweight 261 (43) 341 1.29 (0.98, 1.65) 1.25 (0.94, 1.64) 
Obese 156 (49) 165 1.61 (1.18, 2.17) 1.72 (1.22, 2.33) 
Unknown 26 (43) 35  1.23 (0.66, 2.14) 1.22 (0.57, 2.18) 
Neither depressed nor anxious 289 (42) 395 1.00 1.00 
Depressed or anxious 312 (44) 395 1.01 (0.81, 1.26) 0.90 (0.68, 1.17) 
Recorded site         Knee 367 (50) 361  1.00 1.00 
 Hip 119 (37) 206 0.52 (0.39, 0.69) 0.50 (0.36, 0.67) 
 Hand/wrist 75 (47) 86 0.87 (0.59, 1.24) 1.03 (0.69, 1.48) 
 Foot/ankle 55 (26) 74 0.29 (0.19, 0.40) 0.26 (0.17, 0.38) 
No. of pain sites, median (IQR)c 2 (2 - 3) 2 (1 - 3) 1.11 (1.02, 1.22) 1.04 (0.92, 1.15) 
No pain interference 155 (34) 302 1.00 1.00 
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Pain interference 444 (48) 489 1.70 (1.33, 2.14) 1.45 (1.09, 1.92) 
No analgesic  248 (40) 375 1.00 1.00 
Any analgesicd 368 (46) 436 1.22 (0.97, 1.53) - 
 Basic  77 (44) 100 1.17 (0.81, 1.64) 0.93 (0.62, 1.37) 
 Weak / Moderate opioid 83 (48) 91 1.41 (0.97, 1.94) 1.04 (0.68, 1.49) 
 NSAID 43 (41) 63  1.01 (0.62, 1.55) 0.89 (0.53, 1.40) 
 Strong opioid 165 (48) 182 1.21 (0.90, 1.59) 1.07 (0.79, 1.43) 
a Multilevel logistic regression, level 1 (patient), level 2 (practice), unadjusted 
b
 Multilevel logistic regression, level 1 (patient), level 2 (practice), adjusted for other listed 
variables  
c Self-reported in baseline survey (knee, hip, hand, foot). 
d
 Prescribed on day of index consultation or in following 0-14 days 
CrI = Credible intervals, NSAID = Non-steroidal anti-inflammatory drug 
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Table 3 – Comparison between those with a recorded OA diagnosis and those with a recorded 
non-specific joint pain symptom in new episode consulters 
 OA 
n (%) 
Joint Pain 
n (%) 
OR (95% CrI)a OR (95% CrI)b 
Total 254 (36) 447 - - 
Male 95 (35) 173 1.00 1.00 
Female 159 (37) 274 1.16 (0.82, 1.58) 1.19 (0.81, 1.71) 
Age  50-64 90 (30) 213 1.00 1.00 
 65-74 90 (37) 153 1.41 (0.97, 1.97) 1.59 (1.07, 2.37) 
 75+ 74 (48) 81 2.04 (1.30, 2.96) 2.56 (1.52, 4.03) 
Social class            Low 117 (35) 216 1.00 1.00 
High 130 (39) 206 1.19 (0.85, 1.66) 1.14 (0.77, 1.67) 
Unknown 7 (22) 25  0.52 (0.19, 1.09) 0.39 (0.11, 0.97) 
BMI group       Normal 80 (34) 155 1.00 1.00 
Overweight 101 (35) 186 1.09 (0.73, 1.58) 1.01 (0.65, 1.50) 
Obese 60 (42) 83 1.60 (0.98, 2.49) 1.67 (0.97, 2.64) 
Unknown 13 (36) 23 1.16 (0.49, 2.22) 1.08 (0.41, 2.38) 
Neither depressed nor anxious 133 (37) 222 1.00 1.00 
Depressed or anxious 114 (35) 213 0.87 (0.61, 1.16) 0.79 (0.52, 1.15) 
Recorded site          Knee 144 (42) 203  1.00 1.00 
 Hip 36 (27) 99 0.39 (0.23, 0.62) 0.38 (0.22, 0.60) 
 Hand/wrist 39 (43) 52 1.09 (0.65, 1.68) 1.24 (0.69, 2.01) 
 Foot/ankle 35 (27) 93 0.43 (0.26, 0.67) 0.38 (0.21, 0.64) 
No. of pain sites, median (IQR)c 2 (1 - 3 ) 2 (1 - 3) 1.06 (0.93, 1.22) 1.05 (0.87, 1.25) 
No pain interference 86 (31) 190 1.00 1.00 
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Pain interference 162 (40) 246 1.33 (0.94, 1.59) 1.35 (0.82, 1.99) 
No analgesic  99 (33) 202  1.00 1.00 
Any analgesicd 151 (38) 245 1.22 (0.86, 1.72) - 
 Basic  44 (40) 65 1.43 (0.85, 2.27) 1.31 (0.71, 2.13) 
 Weak / Moderate opioid 34 (38) 55 1.29 (0.74, 2.06) 1.07 (0.58, 1.82) 
 NSAID 15 (35) 28 0.98 (0.45, 1.83) 0.91 (0.36, 1.83) 
 Strong opioid 62 (39) 97 1.16 (0.73, 1.76) 0.97 (0.58, 1.53) 
a Multilevel logistic regression, level 1 (patient), level 2 (practice), unadjusted 
b
 Multilevel logistic regression, level 1 (patient), level 2 (practice), adjusted for other listed 
variables  
c Self-reported in baseline survey (knee, hip, hand, foot). 
d
 Prescribed on day of index consultation or in following 0-14 days 
CrI = Credible intervals, NSAID = Non-steroidal anti-inflammatory drug 
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Table 4 - Comparison between those with a recorded OA diagnosis and those with a recorded 
non-specific joint pain symptom in a) those with a knee problem and b) those with a hip 
problem 
 
  Knee  Hip 
 OA (%) Joint Pain OR (95% CrI)a OA (%) Joint Pain OR (95% CrI)a 
Total 367 (50) 361 - 119 (37) 206 - 
Male 140 (48) 152 1.00 49 (38) 81 1.00 
Female 227 (52) 209 1.15 (0.76, 1.63) 70 (36) 125 0.87 (0.47, 1.46) 
Age  50-64 100 (35) 186 1.00 36 (29) 88 1.00 
 65-74 136 (53) 121 2.81 (1.87, 4.03) 48 (44) 62 1.97 (0.93, 3.62) 
 75+ 131 (71) 54 8.97 (5.32, 14.78) 35 (38) 56 1.69 (0.78, 3.24) 
Social class   Low 169 (49) 175 1.00 59 (38) 98 1.00 
High 186 (53) 166 1.22 (0.84, 1.68) 52 (35) 95 0.73 (0.39, 1.23) 
Unknown 12 (38) 20 0.39 (0.13, 0.85) 8 (38) 13 0.56 (0.13, 1.49) 
BMI group  
Normal 
94 (49) 97 1.00 31 (26) 87 1.00 
Overweight 146 (47) 167 1.06 (0.68, 1.58) 58 (43) 78 2.38 (1.17, 4.23) 
Obese 110 (58) 80 1.92 (1.13, 2.99) 24 (41) 34 2.30 (0.98, 4.72) 
Unknown 17 (50) 17 1.55 (0.55, 3.47) 6 (46) 7 2.50 (0.52, 7.76) 
Neither depressed 
nor anxious 
177 (48) 191 1.00 52 (39) 82 1.00 
Depressed or 
anxious 
184 (53) 164 0.96 (0.63, 1.36) 62 (34) 118 0.78 (0.41, 1.35) 
No. of pain sites, 
median (IQR)b 
2 (2 - 3) 2 (1 - 3) 1.11 (0.93, 1.30) 3 (2 - 4) 3 (2 - 4) 0.90 (0.71, 1.14) 
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No pain 
interference 
90 (39) 142 1.00 21 (24) 65 1.00 
Pain interference 269 (56) 209 1.47 (0.96, 2.21) 94 (41) 138 2.42 (1.09, 4.71) 
No analgesic  149 (49) 157 1.00 43 (35)  80 1.00 
Any analgesicc 218 (52) 204 - 76 (38) 126 - 
 Basic  40 (43) 53 0.64 (0.34, 1.10) 16 (42) 22 1.19 (0.42, 2.61) 
 Weak / 
Moderate opioid 
52 (55) 43 0.83 (0.46, 1.43) 18 (38) 30 1.19 (0.48, 2.53) 
 NSAID 26 (52) 24 0.77 (0.35, 1.51) 13 (31) 29 1.00 (0.37, 2.19) 
 Strong 
opioid 
100 (54) 84 1.07 (0.69, 1.63) 29 (39) 45 1.17 (0.56, 2.23) 
a Multilevel logistic regression, level 1 (patient), level 2 (practice), adjusted for other listed 
variables  
b
 Self-reported in baseline survey (knee, hip, hand, foot). 
c Prescribed on day of index consultation or in following 0-14 days 
CrI = Credible intervals, NSAID = Non-steroidal anti-inflammatory drug 
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Table 5 – Radiographic evidence of OA in those with a knee OA diagnosis or recorded knee 
joint pain symptom 
Radiographic finding OA 
n (%) 
Joint Pain 
n (%) 
OR (95% CrI)a 
No OA   9 (14) 15 (26) 1.00 
Any OA 57 (86) 43 (74) 2.87 (0.95, 6.37) 
Mild OA 14 (21) 13 (22) 2.24 (0.62, 5.92) 
Moderate/Severe OA 43 (65) 30 (52) 2.82 (0.93, 6.78) 
a Multilevel logistic regression, level 1 (patient), level 2 (practice), unadjusted 
CrI = Credible intervals 
 
